Aichi Cancer Center Initial Experience of Intensity Modulated Radiation Therapy for Nasopharyngeal Cancer Using Helical Tomotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 4, 2009, Pages 1129-1134

  Kodaira, Takeshi ^a   Tomita, Natsuo ^a   Tachibana, Hiroyuki ^a   Nakamura, Tatsuya ^a   Nakahara, Rie ^a   Inokuchi, Haruo ^a   Fuwa, Nobukazu ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Helical tomotherapy; IGRT; IMRT; Nasopharyngeal cancer

Indexed keywords

CHEMOTHERAPY; HEALTH RISKS; RADIOTHERAPY;

CARDIAC DISEASE; DURATION TIME; HELICAL TOMOTHERAPY; IGRT; IMRT; INTENSITY-MODULATED RADIATION THERAPIES; LYMPH NODES; NASOPHARYNGEAL CANCER; NASOPHARYNGEAL CARCINOMATA; NEUTROPENIA; PAROTID GLAND FUNCTIONS; PLANNING TARGET VOLUMES; POST TREATMENTS; PRE TREATMENTS; WORLD HEALTH ORGANIZATIONS;

PHYSICAL THERAPY;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CENTER; CANCER PREVENTION; CANCER REGRESSION; CANCER STAGING; CHILD; CLINICAL ARTICLE; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; NASOPHARYNX CANCER; OUTCOME ASSESSMENT; PAROTID REGION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SCHOOL CHILD; SCINTIGRAPHY; TOMOTHERAPY; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR CLASSIFICATION; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CANCER CARE FACILITIES; FEASIBILITY STUDIES; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PAROTID GLAND; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; REMISSION INDUCTION; TOMOGRAPHY, SPIRAL COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 61349144271     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.06.1936     Document Type: Article

References (20)

1. Fuwa N., Kano M., Toita T., et al. Alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil: A preliminary report of Phase II study. Radiother Oncol 61 (2001) 257-260
2. Fleming I.D., Cooper J.S., and Henson D.E. AJCC cancer staging manual. 5th ed. (1997), J.B. Lippincott, Philadelphia
3. Fuwa N., Kodaira T., Kamata M., et al. Phase I study of combination chemotherapy with 5-fluorouracil (5-FU) and nedaplatin (NDP): Adverse effects and recommended dose of NDP administered after 5-FU. Am J Clin Oncol 25 (2002) 565-569
4. Ashamalla H., Guirgius A., Bieniek E., et al. The impact of positron emission tomography/computed tomography in edge delineation of gross tumor volume for head and neck cancers. Int J Radiat Oncol Biol Phys 68 (2007) 388-395
5. Black Q.C., Grills I.S., Kestin L.L., et al. Defining a radiotherapy target with positron emission tomography. Int J Radiat Oncol Biol Phys 60 (2004) 1272-1282
6. Forrest L.J., Mackie T.R., Ruchala K., et al. The utility of megavoltage computed tomography images from a helical tomotherapy system for setup verification purposes. Int J Radiat Oncol Biol Phys 60 (2004) 1639-1644
7. Langen K.M., Zhang Y., Andrews R.D., et al. Initial experience with megavoltage (MV) CT guidance for daily prostate alignments. Int J Radiat Oncol Biol Phys 62 (2005) 1517-1524
8. Anjos D.A., Etchebehere E.C., Santos A.O., et al. Normal values of [99mTc]pertechnetate uptake and excretion fraction by major salivary glands. Nucl Med Commun 27 (2006) 395-403
9. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
10. Kaplan E., and Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 53 (1958) 457-481
11. Mackie T.R., Holmes T., Swerdloff S., et al. Tomotherapy: A new concept for the delivery of dynamic conformal radiotherapy. Med Phys 20 (1993) 1709-1719
12. Ruchala K.J., Olivera G.H., Schloesser E.A., et al. Megavoltage CT on a tomotherapy system. Phys Med Biol 44 (1999) 2597-2621
13. Mutic S., and Low D.A. Whole-body dose from tomotherapy delivery. Int J Radiat Oncol Biol Phys 42 (1998) 229-232
14. Penagaricano J.A., Papanikolaou N., Yan Y., et al. Feasibility of cranio-spinal axis radiation with the Hi-Art tomotherapy system. Radiother Oncol 76 (2005) 72-78
15. Penagaricano J.A., Shi C., and Ratanatharathorn V. Evaluation of integral dose in cranio-spinal axis (CSA) irradiation with conventional and helical delivery. Technol Cancer Res Treat 4 (2005) 683-689
16. van Vulpen M., Field C., Raaijmakers C.P., et al. Comparing step-and-shoot IMRT with dynamic helical tomotherapy IMRT plans for head-and-neck cancer. Int J Radiat Oncol Biol Phys 62 (2005) 1535-1539
17. Fiorino C., Dell'Oca I., Pierelli A., et al. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy. Radiother Oncol 78 (2006) 276-282
18. Sheng K., Molloy J.A., Larner J.M., et al. A dosimetric comparison of non-coplanar IMRT versus helical tomotherapy for nasal cavity and paranasal sinus cancer. Radiother Oncol 82 (2007) 174-178
19. Thomas S.J., and Hoole A.C. The effect of optimization on surface dose in intensity modulated radiotherapy (IMRT). Phys Med Biol 49 (2004) 4919-4928
20. Zeidan O.A., Langen K.M., Meeks S.L., et al. Evaluation of image-guidance protocols in the treatment of head and neck cancers. Int J Radiat Oncol Biol Phys 67 (2007) 670-677